LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 1 of total 1

Search options

Article ; Online: Costos médicos directos de la atención médica de pacientes con cáncer de mama.

de la Cruz-Aguirre, Karla / Cortés-Sanabria, Laura / Salas-González, Efraín / Canales-Muñoz, José Luis / Aguayo-Alcaraz, Guadalupe / Ayala-Cortés, Rafael Adalid / Palomares-Hernández, Carmen Yuritzi

Revista medica del Instituto Mexicano del Seguro Social

2022  Volume 60, Issue 2, Page(s) 107–115

Abstract: Background: The economic cost of breast cancer (BC) treatment and the increase in incidence and prevalence challenges the financial stability of any healthcare system.: Objective: To determine direct medical costs (DMC) of BC treatment and factors ... ...

Title translation Direct medical costs in a cohort of patients with breast cancer.
Abstract Background: The economic cost of breast cancer (BC) treatment and the increase in incidence and prevalence challenges the financial stability of any healthcare system.
Objective: To determine direct medical costs (DMC) of BC treatment and factors associated with DMC.
Material and methods: Partial economic evaluation in a retrospective cohort of 160 patients with a confirmed diagnosis of BC. DMC was considered from the IMSS perspective. Bootstrapping analysis was used to deal with uncertainty and generalized linear model to identify factors associated with DCM.
Results: The total average annual cost of BC treatment was $251,018 mexican pesos. In clinical stage I was $116,123, stage II $242,132, stage III $287,946, and stage IV $358,792 pesos. In progression disease, DMC were more elevate ($380,117) vs. without progression ($172,897), (p < 0.0001). In patients who died, DMC were $357,579 mexican pesos compared to those who survived ($218,699) (p < 0.0001).
Conclusions: The average annual cost of CM treatment was $251,018 pesos. DMCs increase significantly as patients present more advanced stages of the disease. Factors associated with costs were age, stages II, III and the progression of BC.
MeSH term(s) Breast Neoplasms/therapy ; Cohort Studies ; Cost-Benefit Analysis ; Female ; Health Care Costs ; Humans ; Retrospective Studies
Language Spanish
Publishing date 2022-03-01
Publishing country Mexico
Document type Journal Article
ZDB-ID 732133-8
ISSN 2448-5667 ; 0443-5117 ; 0484-7849
ISSN (online) 2448-5667
ISSN 0443-5117 ; 0484-7849
Shelf mark
Zs.B 2225: Show issues Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular
ab Jg. 2022: Lesesaal (EG)
Database MEDical Literature Analysis and Retrieval System OnLINE

More links

Kategorien

To top